Quest Diagnostics, Inc. (DGX)
243.65
-0.22
(-0.09%)
USD |
NYSE |
Aug 25, 15:49
Quest Diagnostics Price to Book Value : 3.566 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.569 |
| August 21, 2026 | 3.577 |
| August 20, 2026 | 3.532 |
| August 19, 2026 | 3.538 |
| August 18, 2026 | 3.458 |
| August 17, 2026 | 3.447 |
| August 14, 2026 | 3.430 |
| August 13, 2026 | 3.455 |
| August 12, 2026 | 3.480 |
| August 11, 2026 | 3.476 |
| August 10, 2026 | 3.478 |
| August 07, 2026 | 3.488 |
| August 06, 2026 | 3.491 |
| August 05, 2026 | 3.452 |
| August 04, 2026 | 3.421 |
| August 03, 2026 | 3.395 |
| July 31, 2026 | 3.410 |
| July 30, 2026 | 3.429 |
| July 29, 2026 | 3.442 |
| July 28, 2026 | 3.453 |
| July 27, 2026 | 3.393 |
| July 24, 2026 | 3.335 |
| July 23, 2026 | 3.335 |
| July 22, 2026 | 3.071 |
| July 21, 2026 | 3.027 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.039 |
| July 17, 2026 | 3.083 |
| July 16, 2026 | 3.065 |
| July 15, 2026 | 2.953 |
| July 14, 2026 | 3.015 |
| July 13, 2026 | 3.035 |
| July 10, 2026 | 3.036 |
| July 09, 2026 | 3.045 |
| July 08, 2026 | 3.047 |
| July 07, 2026 | 3.108 |
| July 06, 2026 | 3.124 |
| July 02, 2026 | 3.157 |
| July 01, 2026 | 3.162 |
| June 30, 2026 | 3.102 |
| June 29, 2026 | 3.204 |
| June 26, 2026 | 3.163 |
| June 25, 2026 | 3.108 |
| June 24, 2026 | 3.061 |
| June 23, 2026 | 2.971 |
| June 22, 2026 | 2.917 |
| June 18, 2026 | 2.938 |
| June 17, 2026 | 2.980 |
| June 16, 2026 | 3.030 |
| June 15, 2026 | 3.047 |
| June 12, 2026 | 3.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Labcorp Holdings, Inc. | 3.165 |
| DaVita, Inc. | -- |
| OPKO Health, Inc. | 0.9386 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.745 |
Price to Book Value Related Metrics
| PE Ratio | 25.85 |
| PS Ratio | 2.366 |
| PEG Ratio | 2.031 |
| Price to Free Cash Flow | 20.27 |
| Price | 243.65 |
| Earnings Yield | 3.87% |
| Market Cap | 26.80B |
| PEGY Ratio | 1.834 |
| Operating PE Ratio | 16.25 |
| Normalized PE Ratio | 24.39 |